Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts
- PMID: 15331547
- DOI: 10.2337/diabetes.53.9.2366
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts
Abstract
Diabetes alters cardiac substrate metabolism. The cardiac phenotype in insulin-resistant states has not been comprehensively characterized. The goal of these studies was to determine whether the hearts of leptin-deficient 8-week-old ob/ob mice were able to modulate cardiac substrate utilization in response to insulin or to changes in fatty acid delivery. Ob/ob mice were insulin resistant and glucose intolerant. Insulin signal transduction and insulin-stimulated glucose uptake were markedly impaired in ob/ob cardiomyocytes. Insulin-stimulated rates of glycolysis and glucose oxidation were 1.5- and 1.8-fold higher in wild-type hearts, respectively, versus ob/ob, and glucose metabolism in ob/ob hearts was unresponsive to insulin. Increasing concentrations of palmitate from 0.4 mmol/l (low) to 1.2 mmol/l (high) led to a decline in glucose oxidation in wild-type hearts, whereas glucose oxidation remained depressed and did not change in ob/ob mouse hearts. In contrast, fatty acid utilization in ob/ob hearts was 1.5- to 2-fold greater in the absence or presence of 1 nmol/l insulin and rose with increasing palmitate concentrations. Moreover, the ability of insulin to reduce palmitate oxidation rates was blunted in the hearts of ob/ob mice. Under low-palmitate and insulin-free conditions, cardiac performance was significantly greater in wild-type hearts. However, in the presence of high palmitate and 1 nmol/l insulin, cardiac performance in ob/ob mouse hearts was relatively preserved, whereas function in wild-type mouse hearts declined substantially. Under all perfusion conditions, myocardial oxygen consumption was higher in ob/ob hearts, ranging from 30% higher in low-palmitate conditions to greater than twofold higher under high-palmitate conditions. These data indicate that although the hearts of glucose-intolerant ob/ob mice are capable of maintaining their function under conditions of increased fatty acid supply and hyperinsulinemia, they are insulin-resistant, metabolically inefficient, and unable to modulate substrate utilization in response to changes in insulin and fatty acid supply.
Similar articles
-
Impaired cardiac function in leptin-deficient mice.Curr Hypertens Rep. 2008 Dec;10(6):448-53. doi: 10.1007/s11906-008-0084-0. Curr Hypertens Rep. 2008. PMID: 18959830 Review.
-
Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.Endocrinology. 2008 Aug;149(8):4043-50. doi: 10.1210/en.2007-1646. Epub 2008 May 1. Endocrinology. 2008. PMID: 18450963 Free PMC article.
-
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.Endocrinology. 2005 Dec;146(12):5341-9. doi: 10.1210/en.2005-0938. Epub 2005 Sep 1. Endocrinology. 2005. PMID: 16141388
-
Fatty acid metabolism is enhanced in type 2 diabetic hearts.Biochim Biophys Acta. 2005 May 15;1734(2):112-26. doi: 10.1016/j.bbalip.2005.03.005. Epub 2005 Apr 9. Biochim Biophys Acta. 2005. PMID: 15904868 Review.
-
Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat.J Appl Physiol (1985). 1991 Oct;71(4):1302-8. doi: 10.1152/jappl.1991.71.4.1302. J Appl Physiol (1985). 1991. PMID: 1757353
Cited by
-
Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation.Redox Biol. 2024 Jul;73:103184. doi: 10.1016/j.redox.2024.103184. Epub 2024 May 5. Redox Biol. 2024. PMID: 38718533 Free PMC article.
-
Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets.Chin Med J (Engl). 2024 Apr 20;137(8):936-948. doi: 10.1097/CM9.0000000000003075. Epub 2024 Mar 25. Chin Med J (Engl). 2024. PMID: 38527931 Free PMC article. Review.
-
The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy.Front Cardiovasc Med. 2023 Dec 6;10:1291450. doi: 10.3389/fcvm.2023.1291450. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38124893 Free PMC article. Review.
-
The Physiological and Pathological Role of Acyl-CoA Oxidation.Int J Mol Sci. 2023 Oct 3;24(19):14857. doi: 10.3390/ijms241914857. Int J Mol Sci. 2023. PMID: 37834305 Free PMC article. Review.
-
Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy.Front Cardiovasc Med. 2023 Sep 1;10:1165302. doi: 10.3389/fcvm.2023.1165302. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37719978 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous